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Numerous precursors of antibacterial peptides with unrelated
sequences share a similar prosequence which belongs to the
cathelicidin family of proteins. The three-dimensional structure of
this cathelicidin motif, which contains two disul®de bonds, has not yet
been reported. The cathelicidin motif (ProS) of the protegrin-3
precursor was overexpressed in Escherichia coli as a His-tagged
protein. The His6 tag was removed by thrombin cleavage. ProS was
puri®ed to homogeneity and single crystals were obtained by the
hanging-drop vapour-diffusion method at pH 3±4. Preliminary X-ray
diffraction analysis indicated that these crystals belong to the
hexagonal space group P6122 or P6522, with unit-cell parameters
a = b = 51.42, c = 134.25 AÊ . These crystals diffracted beyond 2.75 AÊ
(1.9 AÊ at ESRF) and contain one molecule per asymmetric unit.
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1. Introduction
Numerous precursors of antibacterial peptides
with unrelated sequences, including the
protegrin precursors, share a similar pro-
sequence of 96±101 residues and belong to
cathelicidin family (Gennaro et al., 1998;
Gennaro & Zanetti, 2000; Ritonja et al., 1989;
Scocchi et al., 1997; Storici et al., 1996; Wang et
al., 1998; Zanetti et al., 1995, 2000; Zhao et al.,
1994). Protegrins (PG-1 to PG-5, 16±18 resi-
dues) are a family of ®ve antibacterial peptides
isolated from porcine leucocytes (Kokryakov
et al., 1993). They are initially synthesized as a
149-residue precursor (147 residues for PG-2)
devoid of antibacterial activity, in which three
regions have been identi®ed: the signal peptide
(sequence 1±29), the prosequence (sequence
30±130) and the protegrin sequence (sequence
131±148 for PG-1 and PG-3). The Gly149 is
removed in a well known amidation step
(Merkler, 1994; Suzuki et al., 1990; Zhao et al.,
1997). The protegrin prosequence, referred to
as ProS, contains four cysteines engaged in two
disul®de bonds. Their 1±2, 3±4 arrangement
was clearly established for probactenecin-7, a
bovine cathelicidin (Storici et al., 1996). Taking
into account the high degree of sequence
identity between the probactenecin and ProS
sequences (74±78%) and the alignment of the
four cysteines, the disul®de-bond arrangement
of ProS was assumed to be identical to that of
probactenecin. Therefore, the two disul®de
bonds of ProS are Cys85±Cys96 and Cys107±
Cys124. The detailed three-dimensional struc-
ture of this widespread cathelicidin motif is not
yet known. To determine the structure of the
cathelicidin motif of the protegrin-3 precursor,
ProS was overexpressed in E. coli. Here, we
report the overexpression, puri®cation, crys-
tallization and preliminary X-ray diffraction
analysis of the recombinant ProS.
2. Materials and methods
2.1. Overexpression and purification of the
His-tagged ProS
A PCR product containing the coding
sequence of ProS was generated from the
plasmid pBluescript including the pro-
protegrin-3 cDNA (Panyutich et al., 1997). The
cDNA encoding for the ProS sequence
(residues 30±130) was subcloned into the
NdeI/BamHI sites of the pET-15b plasmid
vector (Novagen) leading to the N-terminus in
frame fusion with the His tag. E. coli strain
BL21(DE3), transformed with the recombi-
nant plasmid, was grown in 400 ml of medium
(20 g lÿ1 tryptone, 10 g lÿ1 yeast extract, 5 g lÿ1
sodium citrate, 5 g lÿ1 KH2PO4 adjusted to pH
7.0) containing 100 mg lÿ1 ampicillin. After
overnight growth at 310 K, the culture was
used to inoculate 4 l of the same medium
supplemented with ampicillin (100 mg lÿ1),
MgSO4 (10 mM), glucose (5 g l
ÿ1), biotin
(1 mg lÿ1), thiamine (10 mg lÿ1) and nicotin-
amide (10 mg lÿ1) and grown at 310 K for 3 h.
Expression was induced for 4 h by addition of
1 mM IPTG. The cells were harvested by
centrifugation for 15 min at 8000 rev minÿ1.
Cells, 20 g wet weight, were resuspended in
50 ml of ice-cold buffer A (100 mM Tris±HCl
pH 7.5, 150 mM NaCl) containing 5 mM
benzamidine. The mixture was homogenized
and freezed/thawed three times. The lysate was
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kept on ice and probe-sonicated for 1 min
with 0.1 s bursts at 340 W. Particulate
material was then removed by centrifugation
at 20 000g for 30 min at 277 K. The super-
natant was further clari®ed by centrifugation
at 90 000g for 30 min and applied to a Q-
Sepharose (Amersham Pharmacia Biotech)
column (20  2.6 cm) equilibrated with
buffer A.
The ¯owthrough containing the protein
was applied to an Ni-NTA Super¯ow
(Qiagen) column (2  2.5 cm) equilibrated
with buffer A. The column was washed with
30 ml of buffer A, 50 ml of buffer A
containing 1 M NaCl and then re-equili-
brated with buffer A. The protein was eluted
with 0.5 M imidazole in the above buffer and
10 ml fractions of eluent were analyzed by
Coomassie-staining SDS±PAGE gels. The
protein-containing fractions 1±4 were
pooled and concentrated 20 times using an
Ultrafree (Millipore) ®lter with a MW cutoff
of 5000 Da. Imidazole was removed by
several concentration/dilution cycles with
buffer A. The concentration of the sample
was estimated by UV±visible spectroscopy
using a calculated extinction coef®cient of
2800 molÿ1 cmÿ1 at 280 nm.
2.2. His-tag cleavage and purification of
ProS
The protein was digested at 298 K in the
presence of 2 mM CaCl2 with 10 units of
thrombin per milligram of protein. The
cleavage was complete after 1 h. The protein
was puri®ed by gel ®ltration on a Sephadex
HR-100 (Pharmacia Biotech) column (100
1.6 cm) equilibrated with buffer B (50 mM
sodium phosphate, 50 mM NaCl pH 7.0).
1 ml fractions were collected at a ¯ow rate of
0.6 ml minÿ1. The protein was eluted as a
single peak and the corresponding fractions
pooled and concentrated. About 10±12 mg
of puri®ed ProS were obtained from 20 g
wet weight of cells. Purity was controlled by
Coomassie-staining SDS±PAGE gels, 1H
NMR and mass spectrometry (Fig. 1).
2.3. Crystallization
The hanging-drop vapour-diffusion
method was used to screen and to optimize
the crystallization conditions. The drops
contained equal volumes (1 ml) of ProS
protein solution (35 mg mlÿ1 in 10 mM Tris±
HCl buffer pH 7.0) and reservoir solution.
The optimized reservoir solution consisted
of 1.2±1.4 M ammonium sulfate and 0.1 M
sodium citrate buffer at pH 3.8. Two types of
hexagonal diffraction-quality crystals were
reproducibly obtained within a week at
291 K. From drops containing 1.2 M
ammonium sulfate reservoir solution,
crystals reached dimensions of
about 0.2  0.1  0.05 mm, whereas
larger crystals were obtained from
drops containing 1.4 M ammonium
sulfate reservoir solution (Fig. 2).
Prior to data collection, crystals
were transferred to cryoprotectant
mother liquor supplemented with
30% glycerol and ¯ash-frozen.
3. Results and discussion
Well diffracting crystals of the
recombinant ProS protein, corre-
sponding to the cathelicidin prote-
grin-3 precursor, were obtained.
X-ray data were collected at 100 K
on a MAR Research image-plate
detector (Hamburg, Germany)
mounted on a Rigaku RU-200
rotating-anode generator (Tokyo,
Japan) operating at 40 kV and
90 mA. The crystal-to-detector distance was
140 mm and the oscillation range was 0.5
per ®lm (25 min exposure time). The images
were processed and scaled with the HKL
suite of programs (Otwinowski & Minor,
1997). The autoindexing procedure indi-
cated that the two types of crystals belong to
a primitive hexagonal space group, with
unit-cell parameters a = b = 51.42,
c = 134.25 AÊ . The lattice was assigned to one
of the enantiomorphic space groups P6122
or P6522. Considering a molecular weight of
11 718 Da for the protein, the Matthews
coef®cient was determined to be
2.19 AÊ 3 Daÿ1, assuming one molecule per
asymmetric unit, with a corresponding
solvent content of 44%. Table 1 summarizes
the data-collection statistics. While good-
quality data could be collected to 2.75 AÊ
resolution on a conventional X-ray source,
the same crystal diffracted beyond 1.9 AÊ
resolution using synchrotron radiation
(ESRF, Grenoble, FIP beamline).
Initial attempts to solve the structure by
molecular replacement using various struc-
tures supposed to share a similar global fold
(PDB entries 1cew, 1stf, 1dvd, 1mnl, 1eqk,
1g96) as search models have so far proven
unsuccessful. Screening for heavy-atom
derivatives is now under way.
Figure 1
Molecular mass spectrum of the recombinant ProS. Mass
analysis of the recombinant ProS was performed using the
electrospray mass spectrometry technique (ES-MS) on a VG
Bio-Q quadrupole with a mass range of 4000 Da (Bio-Tech,
Manchester, England) in the positive mode. The protein was
desalted on Zip-Tip (Millipore) and 10 pmol were used for
mass analysis. The calibration was performed using the multiply
charged ions produced by a separate introduction of horse
heart myoglobin (16 951.4 Da).
Figure 2
Photomicrographs of the two types of crystals
obtained from drops containing (a) 1.2 M and (b)
1.4 M ammonium sulfate of the recombinant ProS
overexpressed in E. coli. Typical dimensions are
about 0.1  0.1  0.08 mm and 0.2  0.05  0.05 mm
for A and B, respectively.
Table 1
Data-collection statistics.
Values in parentheses refer to data in the last resolution
shell (2.80±2.75 AÊ ).
Space group P6122 or P6522
Unit-cell parameters (AÊ )
a = b 51.42
c 134.25
Resolution range (AÊ ) 23±2.75
Asymmetric unit content Monomer
Total No. of re¯ections 21019
No. of unique re¯ections 3110
Redundancy 6.6
Average I/(I) 16.1 (3.6)
Completeness (%) 91.3 (58)
Rmerge² (%) 6.2 (28.6)
² Rmerge =
P jIh ÿ hIhij=P Ih .
Acta Cryst. (2001). D57, 1677±1679 Sanchez et al.  Cathelicidin motif of the protegrin-3 precursor 1679
crystallization papers
This research was supported by a grant from
the MinisteÁ re de l'Education Nationale, de
la Recherche et de la Technologie (JFS). We
acknowledge the opportunity to test preli-
minary diffraction data at the ESRF
synchrotron (Grenoble, France) and are
indebted to Dr S. L. Salhi for editorial
revision of the manuscript.
References
Gennaro, R., Scocchi, M., Merluzzi, L. & Zanetti,
M. (1998). Biochim. Biophys. Acta, 1425, 361±
368.
Gennaro, R. & Zanetti, M. (2000). Biopolymers,
55, 31±49.
Kokryakov, V. N., Harwig, S. S., Panyutich, E. A.,
Shevchenko, A. A., Aleshina, G. M., Shamova,
O. V., Korneva, H. A. & Lehrer, R. I. (1993).
FEBS Lett. 327, 231±236.
Merkler, D. J. (1994). Enzyme Microb. Technol.
16, 450±456.
Otwinowski, Z. & Minor, W. (1997). Methods
Enzymol. 276, 307±326.
Panyutich, A., Shi, J., Boutz, P. L., Zhao, C. &
Ganz, T. (1997). Infect. Immun. 65, 978±985.
Ritonja, A., Kopitar, M., Jerala, R. & Turk, V.
(1989). FEBS Lett. 255, 211±214.
Scocchi, M., Wang, S. & Zanetti, M. (1997). FEBS
Lett. 417, 311±315.
Storici, P., Tossi, A., Lenarcic, B. & Romeo, D.
(1996). Eur. J. Biochem. 238, 769±776.
Suzuki, K., Shimoi, H., Iwasaki, Y., Kawahara, T.,
Matsuura, Y. & Nishikawa, Y. (1990). EMBO J.
9, 4259±4265.
Wang, Y., Agerberth, B. & Johansson, J. (1998). J.
Protein Chem. 17, 522±523.
Zanetti, M., Gennaro, R. & Romeo, D. (1995).
FEBS Lett. 374, 1±5.
Zanetti, M., Gennaro, R., Scocchi, M. & Skerlavaj,
B. (2000). Adv. Exp. Med. Biol. 479,
203±218.
Zhao, C., Liaw, L., Lee, I. H. & Lehrer, R. I.
(1997). FEBS Lett. 410, 490±492.
Zhao, C., Liu, L. & Lehrer, R. I. (1994). FEBS
Lett. 346, 285±288.
